Earnings Feed
Start Free
Home/Filings/4/0001855763-21-000004
4//SEC Filing

Baxter Nicholas W 4

Accession 0001855763-21-000004

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 4:52 PM ET

Size

7.0 KB

Accession

0001855763-21-000004

Insider Transaction Report

Form 4
Period: 2021-04-26
Lexaria Bioscience Corp.LEXX
Baxter Nicholas W
Director
Transactions
  • Award

    Stock Options

    2021-04-26+1,500→ 6,500 total
    Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)
Holdings

  • common shares

    11,000

  • Stock Options

    Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (5,000 underlying)
    5,000

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001312326

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:52 PM ET
Size
7.0 KB
View on SEC.gov